Hospital
Camc Plateau Medical Center, INC.
Camc Plateau Medical Center, INC. was paid $3.07M by Medicaid between Apr 2023 and Dec 2024, across 76 billing codes. Its largest line is 99283, emergency room visit (moderate) — 18% of everything it billed.
33Billing provider infoCAMC PLATEAU MEDICAL CENTER, INC.
OAK HILL, WV 25901
OAK HILL, WV 25901
33aNPI1285340877assigned 01/26/2023
33bProvider typeCritical Access Hospital
28Total paid$3.07M
24GClaims58,254
24DCodes billed76
24AFirst – last monthApr 2023 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in West Virginia
Rank by total paid#14 of 24
Median peer was paid$3.57M
This provider vs. median0.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2023 | 30,910 | $1.41M | |
| 2024incomplete | 27,344 | $1.66M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 18% | 4,594 | 4,112 | $559K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 18% | 1,046 | 938 | $545K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 14% | 2,336 | 2,128 | $431K |
| 80053 | Comprehensive metabolic panel | 5.2% | 4,593 | 3,839 | $158K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3.7% | 480 | 426 | $113K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 3.5% | 160 | 142 | $106K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3.3% | 2,701 | 2,195 | $102K |
| 70450 | Computed tomography, head or brain; without contrast material | 3.2% | 446 | 393 | $99K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 3.1% | 116 | 86 | $96K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 2.8% | 176 | 152 | $85K |
| 71045 | Radiologic examination, chest; single view | 2.7% | 2,466 | 2,214 | $84K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.5% | 5,251 | 4,446 | $78K |
64 more codes
| 84484 | 2.4% | 2,292 | $75K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 2.0% | 1,247 | $63K |
| 83735 | 1.5% | 1,952 | $46K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.2% | 1,281 | $37K |
| 81001 | 1.2% | 2,781 | $37K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.0% | 454 | $32K |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,237 | $28K |
| 83690 | <1% | 1,500 | $25K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 740 | $24K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 27 | $22K |
| 83880 | <1% | 407 | $17K | |
| 82150 | <1% | 604 | $15K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 344 | $15K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 557 | $15K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 411 | $14K |
| 71250 | <1% | 46 | $12K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 298 | $12K |
| 83605 | <1% | 666 | $11K | |
| J2704 | Injection, propofol, 10 mg | <1% | 1,710 | $10K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 467 | $9K |
| 85379 | <1% | 273 | $8K | |
| 87040 | <1% | 539 | $7K | |
| 80076 | <1% | 109 | $7K | |
| 80047 | <1% | 206 | $6K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 409 | $6K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 675 | $5K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 420 | $4K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 148 | $4K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 962 | $4K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,342 | $3K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 174 | $3K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,070 | $3K |
| 85730 | <1% | 189 | $3K | |
| 85610 | <1% | 556 | $3K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 61 | $3K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 16 | $2K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 75 | $2K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 60 | $2K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 597 | $2K |
| 88304 | <1% | 43 | $2K | |
| 85027 | <1% | 206 | $2K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 15 | $2K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 74 | $1K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 177 | $1K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 142 | $1K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 657 | $957.21 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 46 | $747.14 |
| C1889 | Implantable/insertable device, not otherwise classified | <1% | 43 | $742.24 |
| J3490 | Unclassified drugs | <1% | 1,885 | $737.70 |
| 80061 | Lipid panel | <1% | 60 | $714.90 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 123 | $656.79 |
| 84439 | <1% | 13 | $534.88 | |
| J0137 | Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg | <1% | 32 | $498.75 |
| 84703 | <1% | 34 | $332.88 | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 15 | $328.89 |
| 73030 | <1% | 15 | $282.95 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 222 | $259.37 |
| 87077 | <1% | 14 | $184.46 | |
| 82550 | <1% | 16 | $138.16 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 17 | $129.36 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 78 | $116.90 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 14 | $42.56 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 28 | $37.08 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | <1% | 18 | $2.80 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHOVIS, CHAD (VP FINANCE)
| Provider | Location | Paid |
|---|---|---|
| Charleston Area Medical Center INC | Charleston, WV | $199.84M |
| Camc Greenbrier Valley Medical Center INC | Ronceverte, WV | $2.36M |
| Camc Greenbrier Valley Medical Center INC | Ronceverte, WV | $795K |
| Camc Greenbrier Valley Medical Center, INC. | Ronceverte, WV | $23K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.